AbCellera Biologics(us:ABCL)

2.09

-6.28%

Updated on 2025-04-02

Open:2.23
Close:2.09
High:2.23
Low:2.06
Prev Close:2.23
Volume:4.29M
Turnover:9.15M
Turnover Ratio:1.44%
Shares:297.99M
MarketCap:622.79M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-3016811376278838.61%183971
2024-03-3116611993623640.85%284756
2023-12-3116111896848340.91%264459
2023-09-3018611903547341.08%193788
2023-06-3021112255620942.38%374394
2023-03-3121112766499844.26%216090
2022-12-3121712735008744.40%337976
2022-09-3019712068828542.23%437152
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Baker Bros. Advisors Lp275256409.37%461588720.15%
2024-03-31Baillie Gifford & Co231800897.89%-864707-3.60%
2024-03-31Voya Investment Management Llc106321343.62%79490.07%
2024-03-31Capital World Investors83512932.84%0
2024-03-31Credit Suisse Ag/45473151.55%-30935-0.68%
2024-03-31Orbimed Advisors Llc41807681.42%0
2024-03-31Arrowmark Colorado Holdings Llc41050951.40%0
2024-03-31Blackrock Inc.39005641.33%-5149-0.13%
2024-03-31Founders Fund Vii Management, Llc37735301.29%0
2024-03-31Federated Hermes, Inc.28154590.96%-302221-9.69%

About

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.
Address:2215 Yukon Street

Market Movers